181
Melphalan and Busulfan Followed By Donor Peripheral Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Multiple Myeloma
Condition(s): Multiple Myeloma and Plasma Cell Neoplasm Last Updated: September 20, 2010Completed
560 Clinical Trials for: “Melphalan”, Page 10 of 28
Hide Studies Not Seeking New Volunteers
182
High-Dose Melphalan Followed by Peripheral Stem Cell Transplant in Treating Patients With Amyloidosis
Condition(s): Multiple Myeloma and Plasma Cell Neoplasm Last Updated: September 30, 2010Completed
183
Safety and Efficacy Study of High Dose Melphalan to Treat Multiple Myeloma
Condition(s): Multiple Myeloma Last Updated: August 1, 2012Recruiting
184
A Study of ADH-1 in Combination With Normothermic Isolated Limb Infusion of Melphalan
Condition(s): Neoplasms Last Updated: December 27, 2010Completed
185
High-Dose Melphalan Plus Peripheral Stem Cell Transplantation in Treating Patients With Primary Systemic Amyloidosis
Condition(s): Multiple Myeloma and Plasma Cell Neoplasm Last Updated: February 6, 2009Completed
186
Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases
Condition(s): Colorectal Cancer; Islet Cell Tumor; Liver Cancer; Metastatic Cancer; Neuroendocrine Carcinoma Last Updated: March 21, 2012Completed
187
Bortezomib, Ascorbic Acid, and Melphalan in Treating Patients With Newly Diagnosed Multiple Myeloma
Condition(s): Multiple Myeloma and Plasma Cell Neoplasm Last Updated: June 30, 2011Completed
188
Melphalan and Thiotepa Followed by Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer in Complete Remission
Condition(s): Ovarian Cancer Last Updated: September 13, 2010Completed
189
Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect
Condition(s): Breast Cancer; Leukemia; Lymphoma; Neuroblastoma; Ovarian Cancer; Sarcoma; Unspecified Adult Solid Tumor, Protocol Specific Last Updated: April 25, 2013Completed
190
Phase 1-2 Study of Total Bone Marrow Irradiation With Helicoidal Tomotherapy in 1st Myeloma Relapse
Condition(s): Multiple Myeloma in Relapse Last Updated: February 19, 2013Recruiting
191
Clofarabine and High-Dose Melphalan Followed by Donor Stem Cell Transplant in Patients With Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Myelodysplastic Syndromes
Condition(s): Leukemia; Myelodysplastic Syndromes Last Updated: July 16, 2012Completed
192
Rituximab, Yttrium Y 90 Ibritumomab Tiuxetan, Melphalan, and Autologous Peripheral Stem Cell Transplant in Treating Patients With Previously Treated Multiple Myeloma
Condition(s): Multiple Myeloma and Plasma Cell Neoplasm Last Updated: January 4, 2013Active, not recruiting
193
Dasatinib in Combination With Melphalan and Prednisone to Treat Relapsed and Refractory Multiple Myeloma Patients
Condition(s): Myeloma Last Updated: June 13, 2011Terminated
194
Expanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to Liver
Condition(s): Metastatic Liver Cancer; Ocular Melanoma; Cutaneous Melanoma Last Updated: February 20, 2013Available
195
Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the Liver
Condition(s): Recurrent Colon Cancer; Liver Metastases; Stage IV Rectal Cancer; Recurrent Rectal Cancer; Stage IV Colon Cancer Last Updated: March 21, 2012Completed
196
High-Dose Melphalan, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma in First Relapse
Condition(s): Multiple Myeloma and Plasma Cell Neoplasm Last Updated: May 10, 2011Completed
197
Isolated Hepatic Perfusion With Melphalan in Treating Patients With Unresectable Colorectal Cancer That Has Metastasized to the Liver
Condition(s): Colorectal Cancer; Metastatic Cancer Last Updated: May 11, 2012Completed
198
Radiation Therapy Using Holmium Ho 166 DOTMP Plus Melphalan and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
Condition(s): Multiple Myeloma and Plasma Cell Neoplasm Last Updated: September 17, 2010Completed
199
Combination Chemotherapy Followed by Melphalan and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Acute Myeloid Leukemia
Condition(s): Leukemia Last Updated: February 6, 2009Active, not recruiting
200
Doxorubicin Hydrochloride Liposome, Melphalan, and Bortezomib in Treating Patients With Relapsed or Refractory Stage I, Stage II, or Stage III Multiple Myeloma
Condition(s): Multiple Myeloma and Plasma Cell Neoplasm Last Updated: November 13, 2008Recruiting
